网站主页 >> CAS数据库列表 >> 4-[(4-CARBOXYBUTYL)AMINO]-1-PIPERIDINECARBOXYLIC ACID
4-[(4-CARBOXYBUTYL)AMINO]-1-PIPERIDINECARBOXYLIC ACID
|
|
|
- CAS号:
- 181467-56-1
- 英文名:
- RPR 121056
- 英文别名:
- RPR 121056;Irinotecan Impurity 43;Irinotecan Related Compound;Irinotecan Related Compound(RPR 121056);APC, RPR 121056 (A major metabolite of Irinotecan);4-[(4-Carboxybutyl)aMino]-1-piperidinecarboxylic Acid;1-Piperidinecarboxylicacid, 4-[(4-carboxybutyl)amino]-,(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-ylester
- 中文名:
- 4-[(4-CARBOXYBUTYL)AMINO]-1-PIPERIDINECARBOXYLIC ACID
- 中文别名:
- 伊立替康杂质43;伊立替康相关杂质;伊立替康相关化合物(RPR 121056);APC,RPR 121056(伊立替康的主要代谢产物)
- CBNumber:
- CB71345664
- 分子式:
- C33H38N4O8
- 分子量:
- 618.67682
- MOL File:
- 181467-56-1.mol
|
|
|
4-[(4-CARBOXYBUTYL)AMINO]-1-PIPERIDINECARBOXYLIC ACID化学性质
-
熔点:
-
166-168?C
-
|
-
储存条件:
-
-20°C Freezer
-
|
-
溶解度:
-
DMSO : 200 mg/mL (323.27 mM; Need ultrasonic)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
Pale Yellow to Light Yellow
-
|
4-[(4-CARBOXYBUTYL)AMINO]-1-PIPERIDINECARBOXYLIC ACID性质、用途与生产工艺
RPR121056 (APC) 是通过 CYP3A4 产生的 Irinotecan (CPT-11) 的代谢产物。Irinotecan (CPT-11) 是一种抗肿瘤药，可抑制 I 型拓扑异构酶 (topoisomerase type I)，引起细胞死亡，并用于大肠癌的研究。Irinotecan 也能直接抑制 AChE。
Topoisomerase type I; AChE
4-[(4-CARBOXYBUTYL)AMINO]-1-PIPERIDINECARBOXYLIC ACID
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-100620 | RPR121056 | | 1 mg | 1550元 |
| 2024/04/30 | HY-100620 | RPR121056 | | 5 mg | 3500元 |
4-[(4-CARBOXYBUTYL)AMINO]-1-PIPERIDINECARBOXYLIC ACID
生产厂家
181467-56-1, 4-[(4-CARBOXYBUTYL)AMINO]-1-PIPERIDINECARBOXYLIC ACID 相关搜索:
- Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
- Pharmaceuticals
- Metabolites & Impurities
- Intermediates & Fine Chemicals
- 伊立替康杂质43
- APC,RPR 121056(伊立替康的主要代谢产物)
- 伊立替康相关化合物(RPR 121056)
- 伊立替康相关杂质
- 181467-56-1
- Irinotecan Impurity 43
- Irinotecan Related Compound(RPR 121056)
- Irinotecan Related Compound
- 1-Piperidinecarboxylicacid, 4-[(4-carboxybutyl)amino]-,(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-ylester
- APC, RPR 121056 (A major metabolite of Irinotecan)
- 4-[(4-Carboxybutyl)aMino]-1-piperidinecarboxylic Acid
- RPR 121056